Drug resistance and the microenvironment: nature and nurture

被引:186
作者
Morin, PJ
机构
[1] NIA, Cellular & Mol Biol Lab, Baltimore, MD 21224 USA
[2] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21224 USA
关键词
chemoresistance; extracellular matrix; collagen IV; collagen VI; cisplatin;
D O I
10.1016/S1368-7646(03)00059-1
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Drug resistance remains a major obstacle to the successful use of chemotherapeutic drugs for cancer therapy. It is well documented that cancer cells can adapt to the presence of chemotherapeutic agents through mutations or expression changes of key genes that control drug metabolism or response to damage. In addition, it is becoming increasingly apparent that the tumor microenvironment can have an important impact on the success of chemotherapy. Indeed, cell-cell and cell-matrix interactions can influence the cancer cells sensitivity to apoptosis and affect drug resistance. A model is proposed in which the tumor cells may actively reorganize their environment to maximize their survival in the presence of anticancer agents. Published by Elsevier Ltd.
引用
收藏
页码:169 / 172
页数:4
相关论文
共 37 条
[1]
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[2]
Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells [J].
Chauhan, D ;
Kharbanda, S ;
Ogata, A ;
Urashima, M ;
Teoh, G ;
Robertson, M ;
Kufe, DW ;
Anderson, KC .
BLOOD, 1997, 89 (01) :227-234
[3]
Positive and negative regulation of cellular sensitivity to anti-cancer drugs by FGF-2 [J].
Coleman, AB .
DRUG RESISTANCE UPDATES, 2003, 6 (02) :85-94
[4]
The tumor microenvironment as a determinant of drug response and resistance [J].
Dalton, WS .
DRUG RESISTANCE UPDATES, 1999, 2 (05) :285-288
[5]
Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance [J].
Damiano, Jason S. .
CURRENT CANCER DRUG TARGETS, 2002, 2 (01) :37-43
[6]
DIGFAUTE MA, 2002, CLIN EXP METASTAS, V19, P161
[7]
EFFECTS OF INTERCELLULAR CONTACT ON REPAIR OF RADIATION-DAMAGE [J].
DURAND, RE ;
SUTHERLAND, RM .
EXPERIMENTAL CELL RESEARCH, 1972, 71 (01) :75-+
[8]
Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy [J].
Fan, MY ;
Chambers, TC .
DRUG RESISTANCE UPDATES, 2001, 4 (04) :253-267
[9]
Mechanisms of cancer drug resistance [J].
Gottesman, MM .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :615-627
[10]
Guo YS, 1998, J CELL PHYSIOL, V175, P141, DOI 10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO